Bacillus Calmette-Guerin Inhibits Apoptosis in Human Urothelial Carcinoma Cell Lines in Response to Cytotoxic Injury

Journal of Urology

Volumn 178, Issue 5, 2007, Pages 2166-2170

  Chen, Fanghong ^a   Zhang, Guanjian ^a   Cao, Yanli ^a   Payne, Ryan ^a   See, William A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

apoptosis; bladder; bladder neoplasms; Mycobacterium bovis

Indexed keywords

ACETYLSALICYLIC ACID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BCG VACCINE; CAMPTOTHECIN; CASPASE 3; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOMYCIN C; TRANSCRIPTION FACTOR AP 1; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; DNA CROSS LINKING; DRUG ANTAGONISM; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCG VACCINE; CAMPTOTHECIN; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CROSS-LINKING REAGENTS; DNA FRAGMENTATION; DNA, NEOPLASM; HUMANS; MITOMYCIN; URINARY BLADDER NEOPLASMS;

EID: 35148865562     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.06.040     Document Type: Article

References (20)

1. O'Donnell M.A. Practical applications of intravesical chemotherapy and immunotherapy in high-risk patients with superficial bladder cancer. Urol Clin North Am 32 (2005) 121
2. Bohle A., and Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 170 (2003) 964
3. Bevers R.F., Kurth K.H., and Schamhart D.H. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br J Cancer 91 (2004) 607
4. Chen F., Zhang G., Iwamoto Y., and See W.A. Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin. J Urol 170 (2003) 605
5. Chen F.H., Crist S.A., Zhang G.J., Iwamoto Y., and See W.A. Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guerin through nuclear factor-kappaB and Ap-1 via an immediate early pathway. J Urol 168 (2002) 786
6. Zhang G., Chen G., Cao T., and See W.A. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway. Urol Oncol 25 (2007) 221
7. Chen F., Zhang G., Iwamoto Y., and See W.A. BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking. BMC Urol 5 (2005) 8
8. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., et al. Cell-cycle arrest versus cell death in cancer therapy. Nat Med 3 (1997) 1034
9. Rajala P., Kaasinen E., Rintala E., Jauhiainen K., Nurmi M., Alfthan O., et al. Cytostatic effect of different strains of Bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha. Urol Res 20 (1992) 215
10. Seow S.W., Rahmat J.N., Mohamed A.A., Mahendran R., Lee Y.K., and Bay B.H. Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (bacillus Calmette-Guerin). J Urol 168 (2002) 2236
11. Fontana D., Bellina M., Galietti F., Scoffone C., Cagnazzi E., Guercio S., et al. Intravesical bacillus Calmette-Guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer. J Urol 162 (1999) 225
12. Boccafoschi C., Montefiore F., Pavesi M., Pastormerlo M., and Betta P.G. Cellular proliferation, expression of p53, EGFR and apoptosis index of healthy mucosa of the bladder with TCC; pre- and post-intravesical BCG immunohistochemical study. Arch Ital Urol Androl 69 (1997) 279
13. Abbas S., and Abu-Amer Y. Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. J Biol Chem 278 (2003) 20077
14. Liu S., Bishop W.R., and Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resistance Updates 6 (2003) 183
15. Shemtov M.M., Cheng D.L., Kong L., Shu W.P., Sassaroli M., Droller M.J., et al. LAK cell mediated apoptosis of human bladder cancer cells involves a pH-dependent endonuclease system in the cancer cell: possible mechanism of BCG therapy. J Urol 154 (1995) 269
16. Rintala E., Jauhiainen K., Kaasinen E., Nurmi M., Alfthan O., and Finnbladder Group. Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. J Urol 156 (1996) 56
17. Shah M.A., and Schwartz G.K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Rev Clin Can Res 7 (2001) 2168
18. Slichenmyer W.J., Rowinsky E.K., Donehower R.C., and Kaufmann S.H. The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 85 (1993) 271
19. Donaldson K.L., Goolsby G.L., and Wahl A.F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57 (1994) 847
20. Denis L. Anaphylactic reactions to repeated intravesical instillation with cisplatin. Lancet 1 (1983) 1378